|
Re: New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:39PM
|
|
Re: Phase III approval rates....
|
4
|
Resverlogix Corp.
|
Jul 12, 2015 03:08PM
|
|
Re: Another Week
|
4
|
Resverlogix Corp.
|
Oct 21, 2022 07:05PM
|
|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:53PM
|
|
Re: TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 27, 2019 02:27PM
|
|
Re: Globe - Lessons from accelerated vaccine development - May 25, 2021
|
4
|
Resverlogix Corp.
|
May 27, 2021 07:08PM
|
|
Insiders info
|
4
|
Resverlogix Corp.
|
Aug 08, 2015 04:22PM
|
|
Re: Sept 30 2022 - Resverlogix streaming video
|
4
|
Resverlogix Corp.
|
Sep 30, 2022 08:37AM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 07:00PM
|
|
Re: Is volume going to turn the corner?
|
4
|
Resverlogix Corp.
|
Nov 08, 2019 08:00AM
|
|
Re: AGM - High Level Summary
|
4
|
Zenith Epigenetics
|
Jan 13, 2016 08:58AM
|
|
Re: Hong Kong stock exchange IPO
|
4
|
Resverlogix Corp.
|
Apr 26, 2018 02:16PM
|
|
Re: Drug Discovery Targeting BRD4
|
4
|
Resverlogix Corp.
|
Oct 04, 2017 05:09PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
4
|
Resverlogix Corp.
|
Mar 26, 2022 07:24AM
|
|
Re: TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 27, 2019 03:00PM
|
|
Re: American Society of Nephrology Kidney Week
|
4
|
Resverlogix Corp.
|
Nov 04, 2017 12:36PM
|
|
Re: No word on...
|
4
|
Resverlogix Corp.
|
Jul 15, 2021 10:46AM
|
|
Long Covid remains a big challenge
|
4
|
Resverlogix Corp.
|
Jul 24, 2023 07:20PM
|
|
Re: RVX announces...THIS IS FROM RVX
|
4
|
Resverlogix Corp.
|
Oct 13, 2017 11:29AM
|
|
The Complement System - Beacon Nov 17 2017
|
4
|
Resverlogix Corp.
|
May 16, 2018 04:26PM
|
